Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Fairfax, Virginia 25 trials found
New Search
Filter
Trial Phase
Study Type
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
PHASE1, PHASE2INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
PHASE1INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
PHASE2INTERVENTIONAL Little Rock, Arkansas +4 more
RECRUITING
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
PHASE2INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Pancreatic Cancer Early Detection Consortium
N/AOBSERVATIONAL Phoenix, Arizona +4 more
RECRUITING
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
PHASE1INTERVENTIONAL Duarte, California +4 more
RECRUITING
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PHASE1, PHASE2INTERVENTIONAL Irvine, California +4 more
RECRUITING
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
PHASE2, PHASE3INTERVENTIONAL Goodyear, Arizona +4 more
RECRUITING
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
PHASE1INTERVENTIONAL Duarte, California +4 more
RECRUITING
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
NAINTERVENTIONAL Goodyear, Arizona +4 more
RECRUITING
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
PHASE2INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
NAINTERVENTIONAL Little Rock, Arkansas +4 more
RECRUITING
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
PHASE2INTERVENTIONAL Atlanta, Georgia +4 more
RECRUITING
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
PHASE1INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
PHASE1INTERVENTIONAL Duarte, California +4 more
RECRUITING
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
PHASE1INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
PHASE1, PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
PHASE1INTERVENTIONAL Fullerton, California +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type